We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

How to Confine Genetically Engineered Organisms

By Biotechdaily staff writers
Posted on 30 Jan 2004
Developers of genetically engineered organisms (GEOs) need to consider how biologic techniques such as induced sterility can prevent transgenic animals and plants from escaping into natural ecosystems and breeding or passing engineered traits to other species, according to a report from the U.S. National Research Council, requested by the U.S. Department of Agriculture (USDA).

Since no single "bioconfinement” method is likely to be 100% effective, developers of GEOs should use more than one method to lower the risk of failure, states the report. Scientists need to conduct more research to understand how well specific methods work. Planned combinations of confinement methods need to be tested in organisms with representative genetic profiles and in a variety of environments. Among the GEOs seen as posing environmental danger are transgenic crops engineered to tolerate herbicides or resist diseases and pests, since they may be able to pass their genes on to weedy relatives. Another example is transgenic fish that could escape and mate with wild counterparts, or plants engineered to produce pharmaceuticals that might harm humans.

"Deciding whether or how to confine a genetically engineered organism cannot be an afterthought,” said T. Kent Kirk, committee chair, and professor emeritus, department of bacteriology, University of Wisconsin (Madison, USA). "Confinement won't be warranted in most cases, but when it is, worst-case scenarios and their probabilities should be considered.”




Related Links:
National Research Council

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Automatic CLIA Analyzer
Shine i6000
New
Hematology Consumables
Bioblood Devices

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
30 Jan 2004  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
30 Jan 2004  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
30 Jan 2004  |   BioResearch